CORRECTION: Paul Mueller Company Announces Its Second Quarter Earnings of 2025
Paul Mueller Company (OTC: MUEL) reported strong Q2 2025 financial results with significant growth across key metrics. Net sales reached $72.6 million in Q2 2025, up from $65.7 million in Q2 2024. The company achieved a net income of $11.6 million ($12.50 per share) compared to $6.8 million ($7.26 per share) in the prior year.
Notable highlights include a substantial increase in backlog to $234.2 million as of June 30, 2025, compared to $187.3 million year-over-year, primarily driven by pharmaceutical customers in the Industrial Equipment segment. The U.S. operations demonstrated particularly strong performance, with domestic backlog growing by $42.4 million to $223.6 million.
Paul Mueller Company (OTC: MUEL) ha riportato risultati finanziari solidi nel secondo trimestre del 2025, con una crescita significativa nei principali indicatori. Le vendite nette hanno raggiunto 72,6 milioni di dollari nel Q2 2025, in aumento rispetto ai 65,7 milioni di dollari del Q2 2024. L'azienda ha registrato un utile netto di 11,6 milioni di dollari (12,50 dollari per azione) rispetto ai 6,8 milioni di dollari (7,26 dollari per azione) dell'anno precedente.
Tra i punti salienti si evidenzia un notevole aumento del portafoglio ordini, che al 30 giugno 2025 è salito a 234,2 milioni di dollari rispetto ai 187,3 milioni di dollari dell'anno precedente, trainato principalmente dai clienti del settore farmaceutico nel segmento Industrial Equipment. Le operazioni negli Stati Uniti hanno mostrato performance particolarmente robuste, con il backlog domestico cresciuto di 42,4 milioni di dollari raggiungendo i 223,6 milioni di dollari.
Paul Mueller Company (OTC: MUEL) reportó sólidos resultados financieros en el segundo trimestre de 2025, con un crecimiento significativo en métricas clave. Las ventas netas alcanzaron 72.6 millones de dólares en el Q2 2025, frente a 65.7 millones en el Q2 2024. La compañía logró un ingreso neto de 11.6 millones de dólares (12.50 dólares por acción) en comparación con 6.8 millones (7.26 dólares por acción) del año anterior.
Entre los aspectos destacados se incluye un aumento sustancial en la cartera de pedidos, que al 30 de junio de 2025 llegó a 234.2 millones de dólares frente a 187.3 millones interanuales, impulsado principalmente por clientes farmacéuticos en el segmento de Equipos Industriales. Las operaciones en EE. UU. mostraron un desempeño especialmente fuerte, con la cartera de pedidos doméstica creciendo en 42.4 millones de dólares hasta 223.6 millones.
Paul Mueller Company (OTC: MUEL)는 2025년 2분기에 주요 지표 전반에서 큰 폭의 성장을 보이며 강력한 재무 실적을 보고했습니다. 2025년 2분기 순매출은 7,260만 달러로 2024년 2분기의 6,570만 달러에서 증가했습니다. 회사는 1,160만 달러의 순이익(주당 12.50달러)을 기록했으며, 이는 전년도의 680만 달러(주당 7.26달러)와 비교됩니다.
주요 내용으로는 2025년 6월 30일 기준 2억 3,420만 달러로 크게 증가한 수주 잔고가 있으며, 이는 전년 동기 대비 1억 8,730만 달러에서 증가한 수치로, 주로 산업 장비 부문의 제약 고객에 의해 견인되었습니다. 미국 내 사업부는 특히 강한 실적을 보였으며, 국내 수주 잔고가 4,240만 달러 증가하여 2억 2,360만 달러에 달했습니다.
Paul Mueller Company (OTC : MUEL) a publié des résultats financiers solides pour le deuxième trimestre 2025, avec une croissance significative sur les principaux indicateurs. Les ventes nettes ont atteint 72,6 millions de dollars au T2 2025, contre 65,7 millions au T2 2024. La société a réalisé un bénéfice net de 11,6 millions de dollars (12,50 dollars par action) comparé à 6,8 millions (7,26 dollars par action) l'année précédente.
Parmi les points marquants, on note une augmentation substantielle du carnet de commandes, qui s'élève à 234,2 millions de dollars au 30 juin 2025, contre 187,3 millions un an plus tôt, principalement portée par les clients pharmaceutiques du segment Équipements Industriels. Les opérations américaines ont affiché une performance particulièrement robuste, avec un carnet de commandes domestique en hausse de 42,4 millions de dollars pour atteindre 223,6 millions.
Paul Mueller Company (OTC: MUEL) meldete starke Finanzergebnisse für das zweite Quartal 2025 mit signifikantem Wachstum bei wichtigen Kennzahlen. Der Nettoumsatz erreichte im Q2 2025 72,6 Millionen US-Dollar, gegenüber 65,7 Millionen US-Dollar im Q2 2024. Das Unternehmen erzielte einen Nettoertrag von 11,6 Millionen US-Dollar (12,50 US-Dollar pro Aktie) im Vergleich zu 6,8 Millionen US-Dollar (7,26 US-Dollar pro Aktie) im Vorjahr.
Besonders hervorzuheben ist der deutliche Anstieg des Auftragsbestands auf 234,2 Millionen US-Dollar zum 30. Juni 2025, im Vergleich zu 187,3 Millionen US-Dollar im Vorjahreszeitraum, hauptsächlich getrieben durch pharmazeutische Kunden im Segment Industrielle Ausrüstung. Die US-Geschäfte zeigten eine besonders starke Performance, wobei der inländische Auftragsbestand um 42,4 Millionen US-Dollar auf 223,6 Millionen US-Dollar wuchs.
- Net income increased by 71% to $11.6 million in Q2 2025
- Backlog grew significantly to $234.2 million, up $46.9 million year-over-year
- Strong cash position with $21.7 million in cash and $29.9 million in marketable securities
- Domestic revenue increased by $6.1 million (11.5%) in Q2 2025
- Operating income improved to $14.5 million from $8.4 million in Q2 2024
- Mueller BV (European operations) saw revenue decline of $2.4 million in first half of 2025
- Selling, General and Administrative expenses increased by 16.8% to $13.3 million in Q2
- Other income decreased significantly to $50,000 from $506,000 in Q2 2024
SPRINGFIELD, Mo., July 25, 2025 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) corrects an earlier release which contained an error in the earnings per share for the three and six months ended June 30, 2025.
PAUL MUELLER COMPANY | ||||||||||||||||||||||
SIX-MONTH REPORT | ||||||||||||||||||||||
Unaudited | ||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||
CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||||||||
Three Months Ended | Six Months Ended | Twelve Months Ended | ||||||||||||||||||||
June 30 | June 30 | June 30 | ||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||
Net Sales | $ | 72,624 | $ | 65,670 | $ | 131,484 | $ | 116,026 | $ | 264,043 | $ | 228,900 | ||||||||||
Cost of Sales | 44,760 | 45,871 | 85,798 | 80,431 | 171,491 | 158,123 | ||||||||||||||||
Gross Profit | $ | 27,864 | $ | 19,799 | $ | 45,686 | $ | 35,595 | $ | 92,552 | $ | 70,777 | ||||||||||
Selling, General and Administrative Expense | 13,332 | 11,417 | 24,865 | 21,775 | 49,338 | 84,743 | ||||||||||||||||
Operating Income (Loss) | $ | 14,532 | $ | 8,382 | $ | 20,821 | $ | 13,820 | $ | 43,214 | $ | (13,966 | ) | |||||||||
Interest Income (Expense) | 578 | 70 | 607 | (1,178 | ) | 1,484 | (1,351 | ) | ||||||||||||||
Other Income | 50 | 506 | 114 | 2,050 | 441 | 3,383 | ||||||||||||||||
Income (Loss) before Provision (Benefit) for Income Taxes | $ | 15,160 | $ | 8,958 | $ | 21,542 | $ | 14,692 | $ | 45,139 | $ | (11,934 | ) | |||||||||
Provision (Benefit) for Income Taxes | 3,531 | 2,154 | 4,985 | 3,439 | 10,163 | (4,817 | ) | |||||||||||||||
Net Income (Loss) | $ | 11,629 | $ | 6,804 | $ | 16,557 | $ | 11,253 | $ | 34,976 | $ | (7,117 | ) | |||||||||
Earnings (Loss) per Common Share –– Basic and Diluted | $ | 12.50 | $ | 7.26 | $ | 17.74 | $ | 11.13 | $ | 37.40 | ($ | 6.79 | ) | |||||||||
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | |||||||||
Six Months Ended | |||||||||
June 30 | |||||||||
2025 | 2024 | ||||||||
Net Income | $ | 16,557 | $ | 11,253 | |||||
Other Comprehensive Income (Loss), Net of Tax: | |||||||||
Foreign Currency Translation Adjustment | 2,015 | (780 | ) | ||||||
Comprehensive Income | $ | 18,572 | $ | 10,473 |
CONSOLIDATED BALANCE SHEETS | |||||||||
June 30 | December 31 | ||||||||
2025 | 2024 | ||||||||
Cash and Cash Equivalents | $ | 21,678 | $ | 21,169 | |||||
Marketable Securities | 29,929 | 24,446 | |||||||
Accounts Receivable, net | 47,032 | 31,266 | |||||||
Inventories (FIFO) | 45,417 | 40,905 | |||||||
LIFO Reserve | (21,899 | ) | (20,146 | ) | |||||
Inventories (LIFO) | 23,518 | 20,759 | |||||||
Current Net Investments in Sales-Type Leases | 54 | 39 | |||||||
Other Current Assets | 5,442 | 4,933 | |||||||
Current Assets | $ | 127,653 | $ | 102,612 | |||||
Net Property, Plant, and Equipment | 63,264 | 50,754 | |||||||
Right of Use Assets | 2,290 | 2,235 | |||||||
Other Assets | 165 | 1,862 | |||||||
Long-Term Net Investments in Sales-Type Leases | 1,932 | 1,211 | |||||||
Total Assets | $ | 195,304 | $ | 158,674 | |||||
Accounts Payable | $ | 12,998 | $ | 17,588 | |||||
Current Maturities and Short-Term Debt | 468 | 3,466 | |||||||
Current Lease Liabilities | 371 | 336 | |||||||
Advance Billings | 39,572 | 26,788 | |||||||
Billings in Excess of Cost | 19,792 | 7,635 | |||||||
Other Current Liabilities | 19,556 | 15,591 | |||||||
Current Liabilities | $ | 92,757 | $ | 71,404 | |||||
Long-Term Debt | 5,499 | 5,096 | |||||||
Other Long-Term Liabilities | 692 | 2,329 | |||||||
Lease Liabilities | 993 | 896 | |||||||
Total Liabilities | $ | 99,941 | $ | 79,725 | |||||
Shareholders' Investment | 95,363 | 78,949 | |||||||
Total Liabilities and Shareholders' Investment | $ | 195,304 | $ | 158,674 |
SELECTED FINANCIAL DATA | |||||||||
June 30 | December 31 | ||||||||
2025 | 2024 | ||||||||
Book Value per Common Share | $ | 102.52 | $ | 84.27 | |||||
Total Shares Outstanding | 930,183 | 936,837 | |||||||
Backlog | $ | 234,212 | $ | 153,685 |
CONSOLIDATED STATEMENT OF SHAREHOLDERS' INVESTMENT | |||||||||||||||||||||||
Common Stock | Paid-in Surplus | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Total | ||||||||||||||||||
Balance, December 31, 2024 | $ | 1,508 | $ | 9,708 | $ | 96,037 | $ | (22,697 | ) | $ | (5,607 | ) | $ | 78,949 | |||||||||
Add (Deduct): | |||||||||||||||||||||||
Net Income | 16,557 | 16,557 | |||||||||||||||||||||
Other Comprehensive Income, Net of Tax | 2,015 | 2,015 | |||||||||||||||||||||
Dividends | (495 | ) | (495 | ) | |||||||||||||||||||
Treasury Stock Acquisition | (1,663 | ) | (1,663 | ) | |||||||||||||||||||
Other | - | ||||||||||||||||||||||
Balance, June 30, 2025 | $ | 1,508 | $ | 9,708 | $ | 112,099 | $ | (24,360 | ) | $ | (3,592 | ) | $ | 95,363 |
CONSOLIDATED STATEMENT OF CASH FLOWS | |||||||||
Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | ||||||||
Operating Activities: | |||||||||
Net Income | $ | 16,557 | $ | 11,253 | |||||
Adjustment to Reconcile Net Income to Net Cash Provided by Operating Activities: | |||||||||
Pension Contributions (Greater) than Expense | - | (16 | ) | ||||||
Depreciation & Amortization | 3,380 | 3,427 | |||||||
Deferred Tax Expense | 288 | - | |||||||
Loss on Disposal of Equipment | 469 | 175 | |||||||
(Gain) on Sales of Equipment | - | (106 | ) | ||||||
(Inc) in Accts and Notes Receivable | (15,765 | ) | (9,354 | ) | |||||
(Inc) in Cost in Excess of Estimated Earnings and Billings | (16 | ) | - | ||||||
(Inc) Dec in Inventories | (2,256 | ) | 1,290 | ||||||
(Inc) in Prepayments | (782 | ) | (2,389 | ) | |||||
(Inc) in Net Investment in Sales-type leases | (579 | ) | (80 | ) | |||||
Dec in Other Assets | 2,026 | 738 | |||||||
(Dec) Inc in Accounts Payable | (4,589 | ) | 4,242 | ||||||
(Dec) Inc in Accrued Income Tax | 913 | (1,165 | ) | ||||||
Inc (Dec) in Other Accrued Expenses | 3,088 | (227 | ) | ||||||
Inc (Dec) in Advanced Billings | 12,784 | (8,519 | ) | ||||||
Inc in Billings in Excess of Costs and Estimated Earnings | 12,156 | 8,306 | |||||||
Inc in Lease Liability for Operating | - | 57 | |||||||
Principal payments of Lease Liability for Operating | (156 | ) | (53 | ) | |||||
Inc (Dec) in Long Term Deferred Tax Liabilities | 17 | (78 | ) | ||||||
(Dec) in Other Long-Term Liabilities | (1,730 | ) | (93 | ) | |||||
Net Cash Provided by Operating Activities | $ | 25,805 | $ | 7,408 | |||||
Investing Activities | |||||||||
Intangibles | - | - | |||||||
Purchases of Marketable Securities | (16,464 | ) | (24,649 | ) | |||||
Proceeds from Sales of Marketable Securities | 10,981 | 38,522 | |||||||
Proceeds from Sales of Equipment | - | 131 | |||||||
Additions to Property, Plant, and Equipment | (13,850 | ) | (6,612 | ) | |||||
Net Cash (Required) for Investing Activities | $ | (19,333 | ) | $ | 7,392 | ||||
Financing Activities | |||||||||
Principal payments of Lease Liability for Financing | (50 | ) | (22 | ) | |||||
(Repayment) of Short-Term Borrowings, Net | (5,186 | ) | (751 | ) | |||||
Proceeds of Short-Term Borrowings, Net | 2,136 | 754 | |||||||
(Repayment) of Long-Term Debt | (1,864 | ) | (422 | ) | |||||
Dividends Paid | (495 | ) | (378 | ) | |||||
Treasury Stock Acquisitions | (1,664 | ) | (11,910 | ) | |||||
Net Cash (Required) for Financing Activities | $ | (7,123 | ) | $ | (12,729 | ) | |||
Effect of Exchange Rate Changes | 1,160 | (545 | ) | ||||||
Net Increase in Cash and Cash Equivalents | $ | 509 | $ | 1,526 | |||||
Cash and Cash Equivalents at Beginning of Year | 21,169 | 1,883 | |||||||
Cash and Cash Equivalents at End of Quarter | $ | 21,678 | $ | 3,409 |
PAUL MUELLER COMPANY
SUMMARIZED NOTES TO THE FINANCIAL STATEMENTS
(In thousands)
A. The chart below depicts the net revenue on a consolidating basis for the three months ended June 30.
Three Months Ended June 30 | |||||||||||
Revenue | 2025 | 2024 | Variance | ||||||||
Domestic | $ | 58,928 | $ | 52,830 | $ | 6,098 | |||||
Mueller BV | $ | 13,796 | $ | 13,164 | $ | 632 | |||||
Eliminations | $ | (100 | ) | $ | (324 | ) | $ | 224 | |||
Net Revenue | $ | 72,624 | $ | 65,670 | $ | 6,954 | |||||
The chart below depicts the net revenue on a consolidating basis for the six months ended June 30.
Six Months Ended June 30 | |||||||||||
Revenue | 2025 | 2024 | Variance | ||||||||
Domestic | $ | 109,005 | $ | 91,707 | $ | 17,298 | |||||
Mueller BV | $ | 22,579 | $ | 24,989 | $ | (2,410 | ) | ||||
Eliminations | $ | (100 | ) | $ | (670 | ) | $ | 570 | |||
Net Revenue | $ | 131,484 | $ | 116,026 | $ | 15,458 | |||||
The chart below depicts the net revenue on a consolidating basis for the twelve months ended June 30.
Twelve Months Ended June 30 | |||||||||||
Revenue | 2025 | 2024 | Variance | ||||||||
Domestic | $ | 219,480 | $ | 180,833 | $ | 38,647 | |||||
Mueller BV | $ | 45,548 | $ | 49,322 | $ | (3,774 | ) | ||||
Eliminations | $ | (985 | ) | $ | (1,255 | ) | $ | 270 | |||
Net Revenue | $ | 264,043 | $ | 228,900 | $ | 35,143 | |||||
The chart below depicts the net income (loss) on a consolidating basis for the three months ended June 30.
Three Months Ended June 30 | |||||||||||
Net Income | 2025 | 2024 | Variance | ||||||||
Domestic | $ | 10,922 | $ | 6,027 | $ | 4,895 | |||||
Mueller BV | $ | 694 | $ | 774 | $ | (80 | ) | ||||
Eliminations | $ | 13 | $ | 3 | $ | 10 | |||||
Net Income | $ | 11,629 | $ | 6,804 | $ | 4,825 | |||||
The chart below depicts the net income (loss) on a consolidating basis for the six months ended June 30.
Six Months Ended June 30 | |||||||||||
Net Income | 2025 | 2024 | Variance | ||||||||
Domestic | $ | 16,350 | $ | 10,075 | $ | 6,275 | |||||
Mueller BV | $ | 200 | $ | 1,148 | $ | (948 | ) | ||||
Eliminations | $ | 7 | $ | 30 | $ | (23 | ) | ||||
Net Income | $ | 16,557 | $ | 11,253 | $ | 5,304 | |||||
The chart below depicts the net income on a consolidating basis for the twelve months ended June 30.
Twelve Months Ended June 30 | |||||||||||
Net Income | 2025 | 2024 | Variance | ||||||||
Domestic | $ | 34,609 | $ | (10,408 | ) | $ | 45,017 | ||||
Mueller BV | $ | 388 | $ | 3,285 | $ | (2,897 | ) | ||||
Eliminations | $ | (21 | ) | $ | 6 | $ | (27 | ) | |||
Net Income (Loss) | $ | 34,976 | $ | (7,117 | ) | $ | 42,093 | ||||
B. June 30, 2025 backlog is
C. We manage our business in the U.S. looking at earnings before tax (EBT) and excluding the effects of LIFO and non-reoccurring events such as the pension settlement. This non-GAAP adjusted EBT (as shown in the table below) is up over the prior year by
Ended June 30 | |||||||||||||||||
Three Months | Six Months | Twelve Months | |||||||||||||||
(In Thousands) | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | |||||||||||
Domestic Net Income | $ | 10,922 | $ | 6,027 | $ | 16,350 | $ | 10,075 | $ | 34,610 | $ | (10,408 | ) | ||||
Income Tax Expense | $ | 3,292 | $ | 1,899 | $ | 4,920 | $ | 3,070 | $ | 10,002 | $ | (4,560 | ) | ||||
Domestic EBT - GAAP | $ | 14,214 | $ | 7,926 | $ | 21,270 | $ | 13,145 | $ | 44,612 | $ | (14,968 | ) | ||||
LIFO Adjustment | $ | 369 | $ | (246 | ) | $ | 1,752 | $ | (463 | ) | $ | 587 | $ | (619 | ) | ||
Pension Adjustment | $ | - | $ | - | $ | - | $ | - | $ | - | $ | 41,774 | |||||
Domestic EBT - Non-GAAP | $ | 14,583 | $ | 7,680 | $ | 23,022 | $ | 12,682 | $ | 45,199 | $ | 26,187 |
D. On May 8, 2025, the tender offer, announced on March 31, 2025, expired with 6,654 shares being tendered for a total of
E. The consolidated financials are affected by the euro to dollar exchange rate when consolidating Mueller B.V., the Dutch subsidiary. The month-end euro to dollar exchange rate was 1.07 for June 2024, 1.04 for December 2024, and 1.17 for June 2025.
This press release contains forward-looking statements that provide current expectations of future events based on certain assumptions. All statements regarding future performance growth, conditions, or developments are forward-looking statements. Actual future results may differ materially from those described in the forward-looking statements due to a variety of factors, including, but not limited to, the factors described in the Company’s Annual Report under “Safe Harbor for Forward-Looking Statements”, which is available at paulmueller.com. The Company expressly disclaims any obligation or undertaking to update these forward-looking statements to reflect any future events or circumstances.
The accounting policies related to this report and additional management discussion and analysis are provided in the 2024 annual report, available at
www.paulmueller.com.
Press Contact: Ken Jeffries | Paul Mueller Company | Springfield, MO 65802 | (417) 575-9346
kjeffries@paulmueller.com | https://paulmueller.com
